Clinicopathological Assessment of DNA Mismatch Repair Protein Expression in Gallbladder Adenocarcinoma Using Immunohistochemistry
Indian Journal of Surgical Oncology · 2026-04 · 17 (4) · 749-754
DOI: 10.1007/s13193-026-02572-0 ↗Kurz gefasst
Fachartikel in der Zeitschrift Indian Journal of Surgical Oncology, online erschienen am 09.03.2026. Verfasst von Ranajoy Ghosh und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of GI Pathology, School of Digestive and Liver Diseases, Institute of Post Graduate Medical Education and Research, Kolkata, India. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Multidisciplinary research unit ,IPGMER KOLKATA.
Abstract (Originalsprache)
Background
Gallbladder adenocarcinoma has limited global prevalence but occurs more frequently in certain regions. The disease is often diagnosed at advanced stages, restricting therapeutic options and contributing to poor outcomes. The molecular mechanisms underlying its development remain largely undefined, complicating the discovery of targeted therapies. Microsatellite instability (MSI), resulting from defective DNA mismatch repair, plays a well-established role in several malignancies; however, its significance in gallbladder adenocarcinoma remains unclear. Characterizing MSI status may help identify patients eligible for novel therapeutic approaches. This study investigates the loss of DNA mismatch repair protein expression in gallbladder adenocarcinoma.
Methods
Samples diagnosed as gallbladder adenocarcinoma were assessed for the expression of four DNA mismatch repair proteins using immunohistochemistry. Antibodies against MLH1, MSH2, PMS2, and MSH6 were employed to evaluate protein expression status. The study included 109 cases, both prospective and retrospective. Cases were included if sufficient paraffin-embedded tissue and relevant clinical data were available. Protein expression results were analysed in relation to clinical parameters and tumor-infiltrating lymphocytes.
Results
The majority of patients were female. Radical cholecystectomy was the most common surgical procedure, while incidentally detected cases were typically managed with laparoscopic cholecystectomy. Most tumors demonstrated moderate differentiation. Immunohistochemistry revealed intact protein expression in 64 cases, whereas 45 cases showed loss of at least one mismatch repair protein. Loss of mismatch repair protein expression was significantly associated with the presence of tumor-infiltrating lymphocytes but not with other clinicopathological features.
Conclusion
Although still incompletely defined, MSI may represent a biologically and clinically relevant subset of gallbladder adenocarcinoma. Clarifying its role could help identify patients who may benefit from targeted or immunotherapy-based treatment strategies. Larger multicenter studies with standardized methodologies are warranted to establish the prevalence, prognostic value, and therapeutic implications of MSI in gallbladder adenocarcinoma.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of GI Pathology, School of Digestive and Liver Diseases, Institute of Post Graduate Medical Education and Research, Kolkata, India.
- Department of Pathology, Institute of Post Graduate Medical Education and Research, Kolkata, India.
- Department of Surgical Gastroenterology, School of Digestive and Liver Diseases, Institute of Post Graduate Medical Education and Research, Kolkata, India.
ORCID-Profile: Ranajoy Ghosh
Förderung
- Multidisciplinary research unit ,IPGMER KOLKATA
Zitieren
APA
Ghosh, R., Mondal, A., Halder, A., Ray, S., & Chatterjee, U. (2026). Clinicopathological Assessment of DNA Mismatch Repair Protein Expression in Gallbladder Adenocarcinoma Using Immunohistochemistry. Indian Journal of Surgical Oncology, 17(4), 749-754. https://doi.org/10.1007/s13193-026-02572-0
Vancouver
Ghosh R, Mondal A, Halder A, Ray S, Chatterjee U. Clinicopathological Assessment of DNA Mismatch Repair Protein Expression in Gallbladder Adenocarcinoma Using Immunohistochemistry. Indian Journal of Surgical Oncology. 2026;17(4):749-754. doi:10.1007/s13193-026-02572-0
BibTeX
@article{Ghosh2026,
author = {Ghosh, Ranajoy and Mondal, Anindita and Halder, Aniket and Ray, Sukanta and Chatterjee, Uttara},
title = {Clinicopathological Assessment of DNA Mismatch Repair Protein Expression in Gallbladder Adenocarcinoma Using Immunohistochemistry},
journal = {Indian Journal of Surgical Oncology},
year = {2026},
volume = {17},
number = {4},
pages = {749--754},
doi = {10.1007/s13193-026-02572-0}
}
EUVIMED